{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:57:27Z","timestamp":1792267047258,"version":"4.4.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007028","name":"Leona M. and Harry B. Helmsley Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001067","name":"Juvenile Diabetes Research Foundation Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001067","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00125-025-06591-4","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T15:58:51Z","timestamp":1765468731000},"page":"631-642","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Evolution of islet autoantibodies in the Environmental Determinants of Islet Autoimmunity (ENDIA) prospective cohort"],"prefix":"10.1007","volume":"69","author":[{"given":"Jennifer J.","family":"Couper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Oakey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan A. S.","family":"Penno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Wentworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dao","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria E.","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aveni","family":"Haynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Vuillermin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Soldatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prudence E.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant","family":"Morahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"McGorm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Wook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma E.","family":"Hamilton-Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Rawlinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Sinnott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard C.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Achenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Colman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the ENDIA Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"issue":"10","key":"6591_CR1","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.2337\/dc21-2612","volume":"45","author":"JP Krischer","year":"2022","unstructured":"Krischer JP, Liu X, Lernmark A et al (2022) Predictors of the initiation of islet autoimmunity and progression to multiple autoantibodies and clinical diabetes: The TEDDY Study. Diabetes Care 45(10):2271\u20132281. https:\/\/doi.org\/10.2337\/dc21-2612","journal-title":"Diabetes Care"},{"issue":"1","key":"6591_CR2","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1038\/s41467-022-28909-1","volume":"13","author":"BC Kwon","year":"2022","unstructured":"Kwon BC, Anand V, Achenbach P et al (2022) Progression of type 1 diabetes from latency to symptomatic disease is predicted by distinct autoimmune trajectories. Nat Commun 13(1):1514. https:\/\/doi.org\/10.1038\/s41467-022-28909-1","journal-title":"Nat Commun"},{"issue":"10","key":"6591_CR3","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.2337\/dc22-1960","volume":"46","author":"BI Frohnert","year":"2023","unstructured":"Frohnert BI, Ghalwash M, Li Y et al (2023) Refining the definition of stage 1 type 1 diabetes: an ontology-driven analysis of the heterogeneity of multiple islet autoimmunity. Diabetes Care 46(10):1753\u20131761. https:\/\/doi.org\/10.2337\/dc22-1960","journal-title":"Diabetes Care"},{"issue":"8","key":"6591_CR4","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.2337\/dc24-0198","volume":"47","author":"M Ghalwash","year":"2024","unstructured":"Ghalwash M, Anand V, Ng K et al (2024) Data-driven phenotyping of presymptomatic type 1 diabetes using longitudinal autoantibody profiles. Diabetes Care 47(8):1424\u20131431. https:\/\/doi.org\/10.2337\/dc24-0198","journal-title":"Diabetes Care"},{"issue":"9","key":"6591_CR5","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.2337\/dc19-2547","volume":"43","author":"K Vehik","year":"2020","unstructured":"Vehik K, Bonifacio E, Lernmark A et al (2020) Hierarchical order of distinct autoantibody spreading and progression to type 1 diabetes in the TEDDY Study. Diabetes Care 43(9):2066\u20132073. https:\/\/doi.org\/10.2337\/dc19-2547","journal-title":"Diabetes Care"},{"issue":"23","key":"6591_CR6","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1001\/jama.2013.6285","volume":"309","author":"AG Ziegler","year":"2013","unstructured":"Ziegler AG, Rewers M, Simell O et al (2013) Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA 309(23):2473\u20132479. https:\/\/doi.org\/10.1001\/jama.2013.6285","journal-title":"JAMA"},{"issue":"43","key":"6591_CR7","doi-asserted-by":"publisher","first-page":"17040","DOI":"10.1073\/pnas.0705894104","volume":"104","author":"JM Wenzlau","year":"2007","unstructured":"Wenzlau JM, Juhl K, Yu L et al (2007) The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci U S A 104(43):17040\u201317045. https:\/\/doi.org\/10.1073\/pnas.0705894104","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6591_CR8","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1196\/annals.1447.029","volume":"1150","author":"JM Wenzlau","year":"2008","unstructured":"Wenzlau JM, Moua O, Sarkar SA et al (2008) SlC30A8 is a major target of humoral autoimmunity in type 1 diabetes and a predictive marker in prediabetes. Ann N Y Acad Sci 1150:256\u2013259. https:\/\/doi.org\/10.1196\/annals.1447.029","journal-title":"Ann N Y Acad Sci"},{"key":"6591_CR9","doi-asserted-by":"publisher","first-page":"1411686","DOI":"10.3389\/fendo.2024.1411686","volume":"15","author":"I Urrutia","year":"2024","unstructured":"Urrutia I, Martinez R, Calvo B et al (2024) Risk for progression to type 1 diabetes in first-degree relatives under 50 years of age. Front Endocrinol (Lausanne) 15:1411686. https:\/\/doi.org\/10.3389\/fendo.2024.1411686","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"6591_CR10","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1007\/s00125-009-1438-0","volume":"52","author":"P Achenbach","year":"2009","unstructured":"Achenbach P, Lampasona V, Landherr U et al (2009) Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk. Diabetologia 52(9):1881\u20131888. https:\/\/doi.org\/10.1007\/s00125-009-1438-0","journal-title":"Diabetologia"},{"issue":"12","key":"6591_CR11","doi-asserted-by":"publisher","first-page":"e4638","DOI":"10.1210\/clinem\/dgaa624","volume":"105","author":"PM Pollanen","year":"2020","unstructured":"Pollanen PM, Ryhanen SJ, Toppari J et al (2020) Dynamics of islet autoantibodies during prospective follow-up from birth to age 15 years. J Clin Endocrinol Metab 105(12):e4638\u2013e4651. https:\/\/doi.org\/10.1210\/clinem\/dgaa624","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"6591_CR12","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.2337\/db24-0814","volume":"74","author":"JP Krischer","year":"2025","unstructured":"Krischer JP, Muller S, You L et al (2025) A comparative analysis of the sensitivity, specificity, concordance, and the 5-year predictive power of diabetes-related autoantibody assays. Diabetes 74(9):1535\u20131546. https:\/\/doi.org\/10.2337\/db24-0814","journal-title":"Diabetes"},{"issue":"1","key":"6591_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2337\/diabetes.53.1.1","volume":"53","author":"K Koczwara","year":"2004","unstructured":"Koczwara K, Bonifacio E, Ziegler AG (2004) Transmission of maternal islet antibodies and risk of autoimmune diabetes in offspring of mothers with type 1 diabetes. Diabetes 53(1):1\u20134. https:\/\/doi.org\/10.2337\/diabetes.53.1.1","journal-title":"Diabetes"},{"key":"6591_CR14","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/1471-2431-13-124","volume":"13","author":"MA Penno","year":"2013","unstructured":"Penno MA, Couper JJ, Craig ME et al (2013) Environmental determinants of islet autoimmunity (ENDIA): a pregnancy to early life cohort study in children at-risk of type 1 diabetes. BMC Pediatr 13:124. https:\/\/doi.org\/10.1186\/1471-2431-13-124","journal-title":"BMC Pediatr"},{"issue":"4","key":"6591_CR15","doi-asserted-by":"publisher","first-page":"e004130","DOI":"10.1136\/bmjdrc-2024-004130","volume":"12","author":"RL Thomson","year":"2024","unstructured":"Thomson RL, Oakey H, Haynes A et al (2024) Environmental Determinants of Islet Autoimmunity (ENDIA) longitudinal prospective pregnancy to childhood cohort study of Australian children at risk of type 1 diabetes: parental demographics and birth information. BMJ Open Diabetes Res Care 12(4):e004130. https:\/\/doi.org\/10.1136\/bmjdrc-2024-004130","journal-title":"BMJ Open Diabetes Res Care"},{"key":"6591_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cca.2015.05.010","volume":"447","author":"G Dunseath","year":"2015","unstructured":"Dunseath G, Ananieva-Jordanova R, Coles R et al (2015) Bridging-type enzyme-linked immunoassay for zinc transporter 8 autoantibody measurements in adult patients with diabetes mellitus. Clin Chim Acta 447:90\u201395. https:\/\/doi.org\/10.1016\/j.cca.2015.05.010","journal-title":"Clin Chim Acta"},{"issue":"5","key":"6591_CR17","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s00125-023-05877-9","volume":"66","author":"I Marzinotto","year":"2023","unstructured":"Marzinotto I, Pittman DL, Williams AJK et al (2023) Islet Autoantibody Standardization Program: interlaboratory comparison of insulin autoantibody assay performance in 2018 and 2020 workshops. Diabetologia 66(5):897\u2013912. https:\/\/doi.org\/10.1007\/s00125-023-05877-9","journal-title":"Diabetologia"},{"issue":"3","key":"6591_CR18","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/cei\/uxad139","volume":"215","author":"CL Williams","year":"2024","unstructured":"Williams CL, Marzinotto I, Brigatti C et al (2024) A novel, high-performance, low-volume, rapid luciferase immunoprecipitation system (LIPS) assay to detect autoantibodies to zinc transporter 8. Clin Exp Immunol 215(3):215\u2013224. https:\/\/doi.org\/10.1093\/cei\/uxad139","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"6591_CR19","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00592-017-1082-y","volume":"55","author":"D Liberati","year":"2018","unstructured":"Liberati D, Wyatt RC, Brigatti C et al (2018) A novel LIPS assay for insulin autoantibodies. Acta Diabetol 55(3):263\u2013270. https:\/\/doi.org\/10.1007\/s00592-017-1082-y","journal-title":"Acta Diabetol"},{"issue":"4","key":"6591_CR20","doi-asserted-by":"publisher","first-page":"565","DOI":"10.2337\/db23-0550","volume":"73","author":"RC Wyatt","year":"2024","unstructured":"Wyatt RC, Grace SL, Brigatti C et al (2024) Improved specificity of glutamate decarboxylase 65 autoantibody measurement using luciferase-based immunoprecipitation system assays. Diabetes 73(4):565\u2013571. https:\/\/doi.org\/10.2337\/db23-0550","journal-title":"Diabetes"},{"issue":"6","key":"6591_CR21","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.2337\/db12-1398","volume":"62","author":"C Nguyen","year":"2013","unstructured":"Nguyen C, Varney MD, Harrison LC, Morahan G (2013) Definition of high-risk type 1 diabetes HLA-DR and HLA-DQ types using only three single nucleotide polymorphisms. Diabetes 62(6):2135\u20132140. https:\/\/doi.org\/10.2337\/db12-1398","journal-title":"Diabetes"},{"issue":"3","key":"6591_CR22","doi-asserted-by":"publisher","first-page":"624","DOI":"10.2337\/dc21-0422","volume":"45","author":"LM Jacobsen","year":"2022","unstructured":"Jacobsen LM, Vehik K, Veijola R et al (2022) Heterogeneity of DKA incidence and age-specific clinical characteristics in children diagnosed with type 1 diabetes in the TEDDY Study. Diabetes Care 45(3):624\u2013633. https:\/\/doi.org\/10.2337\/dc21-0422","journal-title":"Diabetes Care"},{"issue":"12","key":"6591_CR23","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1210\/clinem\/dgab575","volume":"106","author":"X Jia","year":"2021","unstructured":"Jia X, He L, Miao D et al (2021) High-affinity ZnT8 Autoantibodies by Electrochemiluminescence Assay Improve Risk Prediction for Type 1 Diabetes. J Clin Endocrinol Metab 106(12):3455\u20133463. https:\/\/doi.org\/10.1210\/clinem\/dgab575","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"6591_CR24","doi-asserted-by":"publisher","first-page":"e0157962","DOI":"10.1371\/journal.pone.0157962","volume":"11","author":"M Niegowska","year":"2016","unstructured":"Niegowska M, Rapini N, Biet F et al (2016) Seroreactivity against specific L5P antigen from mycobacterium avium subsp. paratuberculosis in children at risk for T1D. PLoS One 11(6):e0157962. https:\/\/doi.org\/10.1371\/journal.pone.0157962","journal-title":"PLoS One"},{"key":"6591_CR25","doi-asserted-by":"publisher","first-page":"102677","DOI":"10.1016\/j.jaut.2021.102677","volume":"122","author":"Y Gu","year":"2021","unstructured":"Gu Y, Merriman C, Guo Z et al (2021) Novel autoantibodies to the \u03b2-cell surface epitopes of ZnT8 in patients progressing to type-1 diabetes. J Autoimmun 122:102677. https:\/\/doi.org\/10.1016\/j.jaut.2021.102677","journal-title":"J Autoimmun"},{"issue":"8","key":"6591_CR26","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.2337\/dci24-0042","volume":"47","author":"M Phillip","year":"2024","unstructured":"Phillip M, Achenbach P, Addala A et al (2024) Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Diabetes Care 47(8):1276\u20131298. https:\/\/doi.org\/10.2337\/dci24-0042","journal-title":"Diabetes Care"},{"issue":"9","key":"6591_CR27","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.2337\/dc16-0181","volume":"39","author":"K Vehik","year":"2016","unstructured":"Vehik K, Lynch KF, Schatz DA et al (2016) Reversion of \u03b2-cell autoimmunity changes risk of type 1 diabetes: TEDDY Study. Diabetes Care 39(9):1535\u20131542. https:\/\/doi.org\/10.2337\/dc16-0181","journal-title":"Diabetes Care"},{"issue":"11","key":"6591_CR28","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1007\/s00125-019-04975-x","volume":"62","author":"CL Williams","year":"2019","unstructured":"Williams CL, Long AE (2019) What has zinc transporter 8 autoimmunity taught us about type 1 diabetes? Diabetologia 62(11):1969\u20131976. https:\/\/doi.org\/10.1007\/s00125-019-04975-x","journal-title":"Diabetologia"},{"issue":"2","key":"6591_CR29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/cei\/uxac087","volume":"210","author":"CL Williams","year":"2022","unstructured":"Williams CL, Fareed R, Mortimer GLM et al (2022) The longitudinal loss of islet autoantibody responses from diagnosis of type 1 diabetes occurs progressively over follow-up and is determined by low autoantibody titres, early-onset, and genetic variants. Clin Exp Immunol 210(2):151\u2013162. https:\/\/doi.org\/10.1093\/cei\/uxac087","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"6591_CR30","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/S2213-8587(23)00190-0","volume":"11","author":"LA Allen","year":"2023","unstructured":"Allen LA, Taylor PN, Gillespie KM, Oram RA, Dayan CM (2023) Maternal type 1 diabetes and relative protection against offspring transmission. Lancet Diabetes Endocrinol 11(10):755\u2013767. https:\/\/doi.org\/10.1016\/S2213-8587(23)00190-0","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"6591_CR31","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.2337\/dc24-2886","volume":"48","author":"M Rewers","year":"2025","unstructured":"Rewers M, Agardh D, Johnson SB et al (2025) Unfolding the mystery of autoimmunity: The Environmental Determinants of Diabetes in the Young (TEDDY) study. Diabetes Care 48(7):1125\u20131135. https:\/\/doi.org\/10.2337\/dc24-2886","journal-title":"Diabetes Care"},{"issue":"8","key":"6591_CR32","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/j.1399-5448.2011.00774.x","volume":"12","author":"WA Hagopian","year":"2011","unstructured":"Hagopian WA, Erlich H, Lernmark A et al (2011) The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants. Pediatr Diabetes 12(8):733\u2013743. https:\/\/doi.org\/10.1111\/j.1399-5448.2011.00774.x","journal-title":"Pediatr Diabetes"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-025-06591-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-025-06591-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-025-06591-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T12:00:41Z","timestamp":1770379241000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-025-06591-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["6591"],"URL":"https:\/\/doi.org\/10.1007\/s00125-025-06591-4","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"assertion":[{"value":"4 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The ENDIA Study Group (October 2024) is composed of the named authors. We thank all the institutions and individuals for their contribution to ENDIA recruitment and follow-up. Lead clinical recruitment\/follow-up sites: The Women\u2019s and Children\u2019s Hospital, Royal Melbourne Hospital, Barwon Health, Monash Health, Children\u2019s Hospital at Westmead, Royal Hospital for Women, St George Hospital, Princess Margaret Hospital\/Perth Children\u2019s Hospital, Mater Mother\u2019s Hospital\/Queensland Children\u2019s Hospital. Lead academic sites: The University of Adelaide\/Robinson Research Institute, WEHI, University of New South Wales, University of Sydney, University of Western Australia\/The Kids Research Institute\/Harry Perkins Institute, University of Melbourne, University of Queensland. We also gratefully acknowledge the participants and their families who contributed to the ENDIA study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Acknowledgements"}},{"value":"Data used in this study were derived from the ENDIA study. Data from the ENDIA study are available upon reasonable request via email to the corresponding author or endia@adelaide.edu.au.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"This research was supported by Breakthrough T1D (formerly JDRF Australia), the recipient of the Commonwealth of Australia grant for Accelerated Research under the Medical Research Future Fund, and with funding from the Leona M. and Harry B. Helmsley Charitable Trust (grant key 3-SRA-2023-1374-M-N, 3-SRA-2020-966-M-N, 1-SRA-2019-871-M-B, 4-SRA-2015-127-M-B), and The National Health and Medical Research Council of Australia (Centre of Research Excellence for the Protection of Pancreatic Beta Cell and project grant APP1025083). The study funders were not involved in the design of the study; the collection, analysis, and interpretation of data; or writing the report; and did not impose any restrictions regarding the publication of the report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 relationships and activities"}},{"value":"JJC, HO, MASP and PGC were involved in the conception, design and conduct of the study and the analysis and interpretation of the results. JJC wrote the first draft of the manuscript, and all authors edited, reviewed and approved the final version of the manuscript. PA, KW, JDB and JMW were involved in the analysis and interpretation of the results. DH, RLT, MEC, EAD, AH, TH, PJV, GS, PEL, GM, KMcG, KWK, SB, EEH-W, WDR, RS and LCH were involved in the design and conduct of the study. JJC and HO are the guarantors of this work and, as such, had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Contribution statement"}}]}}